NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2)

NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2)

There are approximately 25 million patients with type 1 diabetes mellitus (DM1) in the world, a figure that would triple in 2050. Although the optimum is to reach A1c levels <7% to avoid and / or slow down the onset / evolution of chronic complications, only 30% of patients achieve this. Furtherm...

Full description

Bibliographic Details
Main Author: León Litwak
Format: Article
Language:Spanish
Published: Sello Editorial Lugones 2020-07-01
Series:Revista de la Sociedad Argentina de Diabetes
Subjects:
fármacos
diabetes.
Online Access:https://www.revistasad.com/index.php/diabetes/article/view/230
id doaj-928243f44f5b4094a1aebd53c2e3e8d0
record_format Article
spelling doaj-928243f44f5b4094a1aebd53c2e3e8d02020-11-25T03:03:34ZspaSello Editorial LugonesRevista de la Sociedad Argentina de Diabetes0325-52472346-94202020-07-01532Sup161610.47196/diab.v53i2Sup.230177NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2)León Litwak0Hospital Italiano de Buenos Aires. Sociedad Argentina de Diabetes. Ciudad Autónoma de Buenos AiresThere are approximately 25 million patients with type 1 diabetes mellitus (DM1) in the world, a figure that would triple in 2050. Although the optimum is to reach A1c levels <7% to avoid and / or slow down the onset / evolution of chronic complications, only 30% of patients achieve this. Furthermore, carbohydrate (HD) count without adequate general dietary education, associated with intensified insulin therapy (IT), is nowadays linked to a higher incidence of hypoglycemia, obesity and other risk factors such as dyslipidemia (DSL), hypertension (HT), obesity (O) and abdominal obesity (OA) in this population, which generates a very frequent phenotype of patients with DM1 associated with metabolic syndrome (SM).https://www.revistasad.com/index.php/diabetes/article/view/230fármacosdiabetes.
collection DOAJ
language Spanish
format Article
sources DOAJ
author León Litwak
spellingShingle León Litwak
NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2)
Revista de la Sociedad Argentina de Diabetes
fármacos
diabetes.
author_facet León Litwak
author_sort León Litwak
title NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2)
title_short NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2)
title_full NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2)
title_fullStr NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2)
title_full_unstemmed NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2)
title_sort non-insulin drugs in diabetes mellitus type 1 (metformine, idpp-4, pramlintida, aglp-1, isglt-2)
publisher Sello Editorial Lugones
series Revista de la Sociedad Argentina de Diabetes
issn 0325-5247
2346-9420
publishDate 2020-07-01
description There are approximately 25 million patients with type 1 diabetes mellitus (DM1) in the world, a figure that would triple in 2050. Although the optimum is to reach A1c levels <7% to avoid and / or slow down the onset / evolution of chronic complications, only 30% of patients achieve this. Furthermore, carbohydrate (HD) count without adequate general dietary education, associated with intensified insulin therapy (IT), is nowadays linked to a higher incidence of hypoglycemia, obesity and other risk factors such as dyslipidemia (DSL), hypertension (HT), obesity (O) and abdominal obesity (OA) in this population, which generates a very frequent phenotype of patients with DM1 associated with metabolic syndrome (SM).
topic fármacos
diabetes.
url https://www.revistasad.com/index.php/diabetes/article/view/230
work_keys_str_mv AT leonlitwak noninsulindrugsindiabetesmellitustype1metformineidpp4pramlintidaaglp1isglt2
_version_ 1724685055165464576

Similar Items